Staphylococcal enterotoxin C injection in combination with ascorbic acid promotes the differentiation of bone marrow-derived mesenchymal stem cells into osteoblasts in vitro

被引:28
作者
Wan, Xiao-Chen [2 ]
Liu, Cui-Ping [2 ]
Li, Meng [2 ]
Hong, Dun [1 ,2 ]
Li, Dong-Mei [2 ]
Chen, Hai-Xiao [1 ]
Li, Ji-Cheng [2 ]
机构
[1] Zhejiang Prov Taizhou Hosp, Dept Orthoped, Linhai 317000, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China
关键词
staphylococcal enterotoxin C injection; ascorbic acid; bone marrow-derived mesenchymal stem cells; differentiation; osteoblasts;
D O I
10.1016/j.bbrc.2008.06.037
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Staphylococcal enterotoxin C injection is established as a clinical therapy for delayed healing or disunion of bone fractures. In the present study, the effects of staphylococcal enterotoxin C injection in combination with ascorbic acid (SEC-AA) on the differentiation of bone marrow-derived mesenchymal stem cells (MSCs) and their influences on the mineralization of osteoblasts were investigated. SEC-AA treatment induced increased levels of alkaline phosphatase activity in MSCs and increased numbers of alizarin red-stained calcified nodules, indicating enhanced differentiation of MSCs into osteoblasts. The findings demonstrated that SEC-AA promoted the differentiation of MSCs into osteoblasts and accelerated the cytopoiesis of osteoblasts. Our data provide a cytological model for bone fracture therapy aimed at shortening the time required for healing and improving the clinical outcome, and also provide a theoretical basis for inducible differentiation of MSCs, mineralization of osteoblasts and reconstruction of bone tissues. Crown Copyright (C) 2008 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:488 / 492
页数:5
相关论文
共 17 条
[1]
Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021
[2]
Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow [J].
Colter, DC ;
Class, R ;
DiGirolamo, CM ;
Prockop, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3213-3218
[3]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317
[4]
Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue [J].
Kern, Susanne ;
Eichler, Hermann ;
Stoeve, Johannes ;
Klueter, Harald ;
Bieback, Karen .
STEM CELLS, 2006, 24 (05) :1294-1301
[5]
CHARACTERIZATION OF NOVEL TYPE C-STAPHYLOCCAL ENTEROTOXINS - BIOLOGICAL AND EVOLUTIONARY IMPLICATIONS [J].
MARR, JC ;
LYON, JD ;
ROBERSON, JR ;
LUPHER, M ;
DAVIS, WC ;
BOHACH, GA .
INFECTION AND IMMUNITY, 1993, 61 (10) :4254-4262
[6]
Vitamin C supplement use and bone mineral density in postmenopausal women [J].
Morton, DJ ;
Barrett-Connor, EL ;
Schneider, DL .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (01) :135-140
[7]
Characterization of osteoblastic differentiation of stromal cell line ST2 that is induced by ascorbic acid [J].
Otsuka, E ;
Yamaguchi, A ;
Hirose, S ;
Hagiwara, H .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 1999, 277 (01) :C132-C138
[8]
Mechanobiology of mesenchymal stem cells and their use in cardiovascular repair [J].
Park, Jennifer S. ;
Huang, Ngan F. ;
Kurpinski, Kyle T. ;
Patel, Shyam ;
Hsu, Steve ;
Li, Song .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 :5098-5116
[9]
Porada Christopher D, 2006, Curr Stem Cell Res Ther, V1, P365
[10]
Osteoclast differentiation requires ascorbic acid [J].
Ragab, AA ;
Lavish, SA ;
Banks, MA ;
Goldberg, VM ;
Greenfield, EM .
JOURNAL OF BONE AND MINERAL RESEARCH, 1998, 13 (06) :970-977